BioSpace News Archive

Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe

Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection) pre-filled syringe, the first and only FDA-approved neostigmine–glycopyrrolate combination product in the U.S.

June 12, 2023
·
4 min read
C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation

C3i Center Inc and Paladin Labs Inc., a subsidiary of Endo International plc, have partnered to launch a complimentary clinical testing program for the diagnosis of the T315I mutation in Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia patients in Canada.

June 12, 2023
·
2 min read
Genetown

Oculis Wins the 2023 Icelandic Knowledge Award from the Icelandic Association of Business and Economics

Oculis Holding AG announced it has won the 2023 Knowledge Award from the Icelandic Association of Business and Economics.

June 12, 2023
·
5 min read
BioMidwest

Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced an agreement with The University of Texas MD Anderson Cancer Center to support research focused on metastatic renal cell carcinoma treatment selection and response.

June 12, 2023
·
3 min read
Policy

Windtree Announces Notice of Allowance from the US Patent and Trademark Office for a Group of SERCA2a Activators with a Dual Mechanism

Windtree Therapeutics, Inc., a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, reported that the United States Patent and Trademark Office has issued a Notice of Allowance for its patent application covering the Company’s dual mechanism SERCA2a Activators.

June 12, 2023
·
7 min read
Drug Development

Salarius Pharmaceuticals Presents SP-3164 Targeted Protein Degrader Preclinical Data at the European Hematology Association 2023 Hybrid Congress

Salarius Pharmaceuticals, Inc. announces the presentation of a poster related to the company’s novel molecular glue, SP-3164, at the European Hematology Association 2023 Hybrid Conference, which was held in Frankfurt, Germany and virtually June 8-11, 2023.

June 12, 2023
·
6 min read
Achilles Therapeutics to Present at Upcoming June 2023 Conferences

Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, announced that the Company will be taking part in the following conferences in June.

June 12, 2023
·
2 min read
Genetown

Keros Therapeutics Announces Update to Participation at the Goldman Sachs 44th Annual Global Healthcare Conference

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS) today announced that it will not be participating in the previously announced fireside chat presentation during the Goldman Sachs 44th Annual Healthcare Conference on Wednesday, June 14, 2023.

June 12, 2023
·
1 min read
BioMidwest

Daxor Corporation to Participate in the Maxim Group Virtual Healthcare Conference

Daxor Corporation, the global leader in blood volume measurement technology, announced that Michael Feldschuh, CEO and President has been invited to present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest.

June 12, 2023
·
2 min read
Biotech Beach

Bionano Announces 2023 Winners of its Innovator Research Grant Program

Bionano Genomics, Inc. announced the 2023 winners of its Innovator Research Grant program, including grand prize winner Dr. Michael Khodadoust at Stanford University.

June 12, 2023
·
7 min read